Hoth Therapeutics, Inc. (HOTH)
NASDAQ: HOTH · Real-Time Price · USD
0.734
-0.046 (-5.86%)
At close: Apr 28, 2026, 4:00 PM EDT
0.751
+0.017 (2.30%)
After-hours: Apr 28, 2026, 5:27 PM EDT
Hoth Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Selling, General & Admin | 6.41 | 4.97 | 4.21 | 6.13 | 6.57 | |
| Research & Development | 5.95 | 3.25 | 3.74 | 4.93 | 7.53 | |
| Operating Expenses | 12.36 | 8.22 | 7.95 | 11.07 | 14.1 | |
| Operating Income | -12.36 | -8.22 | -7.95 | -11.07 | -14.1 | |
| Interest & Investment Income | 0 | 0.03 | 0.05 | 0.07 | - | |
| Other Non Operating Income (Expenses) | -0.11 | - | - | 0.45 | -0.06 | |
| EBT Excluding Unusual Items | -12.47 | -8.19 | -7.9 | -10.55 | -14.16 | |
| Gain (Loss) on Sale of Investments | - | -0 | -0.2 | -0.82 | -0.15 | |
| Pretax Income | -12.47 | -8.19 | -8.11 | -11.37 | -14.31 | |
| Net Income | -12.47 | -8.19 | -8.11 | -11.37 | -14.31 | |
| Preferred Dividends & Other Adjustments | - | - | - | -0 | - | |
| Net Income to Common | -12.47 | -8.19 | -8.11 | -11.37 | -14.31 | |
| Shares Outstanding (Basic) | 14 | 6 | 3 | 1 | 1 | |
| Shares Outstanding (Diluted) | 14 | 6 | 3 | 1 | 1 | |
| Shares Change (YoY) | 116.56% | 87.00% | 184.69% | 34.07% | 80.63% | |
| EPS (Basic) | -0.90 | -1.28 | -2.38 | -9.50 | -16.02 | |
| EPS (Diluted) | -0.90 | -1.28 | -2.38 | -9.50 | -16.02 | |
| Free Cash Flow | -9.8 | -6.98 | -8.45 | -9.3 | -12.09 | |
| Free Cash Flow Per Share | -0.71 | -1.09 | -2.48 | -7.76 | -13.54 | |
| EBITDA | - | - | - | - | -14.1 | |
| D&A For EBITDA | - | - | - | - | 0 | |
| EBIT | -12.36 | -8.22 | -7.95 | -11.07 | -14.1 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.